| Net Cash Provided by (Used in) Operating Activities |
-10,045 |
USD |
-1.1% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
21,126 |
USD |
|
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1,081,829 |
USD |
-4.3% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
468,590 |
USD |
+8.2% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
468,590 |
USD |
+8.2% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
-35,709 |
USD |
+10% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
460,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1,032,917 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
4,446 |
USD |
|
Q4 2024 |
FY 2024 |
| Current Federal Tax Expense (Benefit) |
12,510 |
USD |
-42.9% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |